University of Utah
BioResearch Product Faire™
The University of Utah is recognized as a Top-Tier 1 research university by the Carnegie Classification of Institutions in Higher Education. According to the Vice President of Research the University was awarded 2,326 grants in 2018 and had $515 million in research funding. According to the National Institutes of Health, the university received $152,843,112 from them this year.Read More
The NIH awarded $11.5 million grant to The University of Utah to Study Sarcomagenesis.Read More
The National Institutes of Health have recently been making a push for life science researchers across the country to address gender biases in their studies. In conjunction with these efforts, the NIH announced this September that it will give out $10.1 million in grants to more than 80 scientists studying a range of subjects, as long as the researchers agree to include females in their studies.Read More
Leukemia is a cancer that’s unusual in that it begins in the bone marrow and invades the blood. The most prominent treatment options – drugs called tyrosine kinase inhibitors – have allowed for a 95 percent survival rate over the past five years and also allow leukemia patients to lead relatively normal lives.
"Fortunately, the problems we are studying affect a minority of chronic myeloid leukemia patients, but still, this leaves some patients with no good treatment option at all," said lead author and University of Utah life science researcher Dr. Thomas O'Hare. "Our goal is to have a tyrosine kinase inhibitor option for every patient."Read More